This Article Full Text Full Text (PDF) All Versions of this Article: 34/6/1497    most recent 01.STR.0000070424.38138.30v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsurutani, H. Articles by Suzuki, S. Search for Related Content PubMed PubMed Citation Articles by Tsurutani, H. Articles by Suzuki, S. Related Collections Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2003;34:1497.)
© 2003 American Heart Association, Inc.

Original Contributions

Effects of Thrombin Inhibitor on Thrombin-Related Signal Transduction and Cerebral Vasospasm in the Rabbit Subarachnoid Hemorrhage Model

From the Department of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Japan.

Correspondence to Hisanobu Tsurutani, MD, Department of Neurosurgery, Hirosaki University, School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8216 Japan. E-mail hisamd{at}ca-3.so.net.jp

Background and Purpose— Thrombin is activated in the cerebrospinal fluid (CSF) after a subarachnoid hemorrhage (SAH). However, the relationship between thrombin and cerebral vasospasm has not yet been fully established. The aim of this study was to investigate the possibility of thrombin as a causative factor for cerebral vasospasm and to delineate the signal transduction mechanism that results in thrombin-inducing sustained vasoconstriction in cerebral vasospasm.

Methods— In the SAH group, SAH was simulated by the 2-hemorrhage rabbit model. In the treatment group, antithrombin III (AT-III) was injected into the cisterna magna just before production of the SAH. CSF samples were obtained serially to measure D-dimer with latex photometric immunoassay. On day 4, the basilar artery was excised after perfusion-fixation. The degree of cerebral vasospasm was evaluated by measuring the cross-sectional area of each basilar arterial lumen, and the expression of mitogen-activated protein kinase (MAPK) in the vascular wall was examined with an immunohistochemical technique.

Results— In the treatment group, the value of D-dimer on day 4 was 0.83±0.07 µg/mL, which was statistically significantly lower than that in the nontreated SAH group (2.49±0.09 µg/mL, P<0.01). The cross-sectional area of the arterial lumen in the treatment group was 3.67x10^5±1.58x10⁴ square pixels, which was statistically significantly larger than that in the nontreated SAH group (2.60x10^5±2.29x10⁴ square pixels; P<0.01). MAPK was detected diffusely in the vascular smooth muscle cell layer in the nontreated SAH group, but it was absent in the treatment group.

Conclusions— Inhibition of thrombin activity leads to amelioration of cerebral vasospasm and suppression of MAPK diphosphorylation. This suggests that thrombin and its related signal transduction, including the MAPK cascade, appear to play an important role in the pathogenesis of cerebral vasospasm after SAH.

Key Words: subarachnoid hemorrhage • thrombin • vasospasm • rabbits

This article has been cited by other articles:

				Y. Kai, K. Hirano, Y. Maeda, J. Nishimura, T. Sasaki, and H. Kanaide Prevention of the Hypercontractile Response to Thrombin by Proteinase-Activated Receptor-1 Antagonist in Subarachnoid Hemorrhage Stroke, December 1, 2007; 38(12): 3259 - 3265. [Abstract] [Full Text] [PDF]

				L. Wang, J. X. Shi, H. X. Yin, C. Y. Ma, and Q. R. Zhang The Influence of Subarachnoid Hemorrhage on Neurons: An Animal Model Ann. Clin. Lab. Sci., January 1, 2005; 35(1): 79 - 85. [Abstract] [Full Text] [PDF]